Pfizer is jockeying for full FDA approval of its oral antiviral COVID-19 treatment, Paxlovid, which would allow the company to sell the drug commercially. Read More

The company said the delivery of the additional doses will begin immediately and will be completed no later than August 5. Read More

The companies plan to deliver doses as soon as this summer and will continue into the fourth quarter of this year. Read More

Results from the two assays are comparable to high-sensitivity RT-PCR tests, the company said. Read More

The device delivers hospital-grade HEPA filtration and germicidal ultraviolet irradiation. Read More

The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19 to 2 yesterday in favor of including a SARS-CoV-2 Omicron component in COVID-19 booster shots. Read More

The test can be used for qualitative detection of nucleic acid from the SARS-CoV-2 coronavirus from nasal swab samples from individuals suspected by their healthcare provider of being infected with COVID-19. Read More

Sanofi said the immunogenicity data support the use of the bivalent vaccine against variants including Omicron. Read More

Samples should only be taken for this test from individuals who are 15 days or more post symptom onset, the FDA said. Read More

Moderna is also collaborating with the UK’s National Institute for Health Research on a phase 3 study investigating the company’s bivalent Omicron-containing booster candidate. Read More

Both test systems are now available to laboratories in countries that accept the CE mark, the company said. Read More

The vaccine produced a detectable neutralizing response against the spike protein mutation D614G in 84 percent of individuals. Read More